BAM
Blueshift Asset Management’s Arcus Biosciences RCUS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-8,327
| Closed | -$263K | – | 953 |
|
|
2022
Q1 | $263K | Buy |
+8,327
| New | +$263K | 0.02% | 659 |
|
|
2021
Q4 | – | Sell |
-11,816
| Closed | -$412K | – | 1164 |
|
|
2021
Q3 | $412K | Sell |
11,816
-13,287
| -53% | -$463K | 0.02% | 702 |
|
|
2021
Q2 | $689K | Buy |
+25,103
| New | +$689K | 0.04% | 456 |
|
|
2020
Q4 | – | Sell |
-19,491
| Closed | -$334K | – | 844 |
|
|
2020
Q3 | $334K | Sell |
19,491
-6,932
| -26% | -$119K | 0.05% | 423 |
|
|
2020
Q2 | $654K | Buy |
+26,423
| New | +$654K | 0.11% | 270 |
|